Fig. 8 SOD2 overexpression in normal tissues does not compromise the cytotoxic efficacy of RT. SOD2 overexpression in normal tissues does not compromise.

Slides:



Advertisements
Similar presentations
Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and Adiposity by Alice P. Liou, Melissa Paziuk, Jesus-Mario Luevano, Sriram.
Advertisements

Fig. 1. TP is highly expressed in myeloma.
Fig. 6. AZD6738 induces DNA damage and apoptosis and exhibits antitumor efficacy in xenograft models of high-risk medulloblastoma and neuroblastoma. AZD6738.
Fig. 5. Protective efficacy of the combination of PGT121 + PGDM1400 against a mixed SHIV challenge in rhesus monkeys. Protective efficacy of the combination.
Fig. 2. Bestatin treatment improves tail anatomy and restores lymphatic function. Bestatin treatment improves tail anatomy and restores lymphatic function.
Fig. 2 miRNA181a targets NFAT5 in human CD4+ T cells.
In vivo prophylactic and therapeutic efficacy of C12G6 in mice
Fig. 6. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex vivo. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex.
Fig. 8. In vivo suppression of MM by CMLD
Fig. 2 Maraba treatment results in complete responses in the window of opportunity setting. Maraba treatment results in complete responses in the window.
Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.
MRSA virulence proteins cause LMC death and diminished CLV function
Fig. 6. Increased efficacy of immunotherapy in lymphangiogenic B16 melanomas depends on CCR7 signaling before therapy and local activation and expansion.
Fig. 1. Identification of SE-associated lncRNAs.
Maraba treatment sensitizes 4T1 tumors to immune checkpoint blockade
Fig. 2. GPC3 expression in normal and tumor tissues.
Expression of CD36 and psap in a TMA of human ovarian cancer patients
Fig. 1 Irradiation with 50 Gy/3 fractions generates LAE characterized by SOD2 depletion and CTGF overexpression. Irradiation with 50 Gy/3 fractions generates.
Fig. 4. In vivo analysis of slpA mutant in the Syrian Golden hamster.
Fig. 5. Vascularization of human liver seed grafts.
Fig. 4. Antitumor efficacy of ERY974 against various cancer types.
Dot plots of trisomic versus fetal fractions for cohorts 1 and 2
Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.
Fig. 5 Combination intravenous reovirus and checkpoint inhibition in an orthotopic syngeneic brain tumor model. Combination intravenous reovirus and checkpoint.
Fig. 4. MATE1 transcription in RCC.
Fig. 5 Hypoxic tumors from obese mice associate with increased production of IL-6 by adipocytes and myeloid cells. Hypoxic tumors from obese mice associate.
Fig. 3 In situ vaccination with CpG and anti-OX40 is therapeutic in a spontaneous tumor model. In situ vaccination with CpG and anti-OX40 is therapeutic.
Fig. 4. BET inhibition sensitizes HR-proficient tumors to PARPi treatment in vivo. BET inhibition sensitizes HR-proficient tumors to PARPi treatment in.
Fig. 1. Experimental workflow of the dAST method and computationally estimated operational space. Experimental workflow of the dAST method and computationally.
The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and.
Fig. 7 BRD0705 impairs colony formation in AML cell lines and patient cells and shows in vivo efficacy in multiple AML mouse models. BRD0705 impairs colony.
Fig. 4 DMF enhances VSVΔ51 therapeutic efficacy in syngeneic and xenograft tumor models. DMF enhances VSVΔ51 therapeutic efficacy in syngeneic and xenograft.
Fig. 7. KIF11 informs patient prognosis, and targeting improves survival in a preclinical model. KIF11 informs patient prognosis, and targeting improves.
Fig. 2. Resistance to S63845-induced apoptosis through loss of BAK or elevated BCL-XL. Resistance to S63845-induced apoptosis through loss of BAK or elevated.
Fig. 5 Local gel scaffold for T cell memory response.
Fig. 4. Improved tumor response to docetaxel in TNBC and trastuzumab in HER2-amplified PDX models with the addition of S Improved tumor response.
Fig. 8 SQLE inhibitor terbinafine suppresses NAFLD-HCC growth in vitro and in vivo. SQLE inhibitor terbinafine suppresses NAFLD-HCC growth in vitro and.
HECTD2 knockdown ameliorates Pseudomonas-induced lung injury in vivo
Fig. 7. Genetic ablation of UCP2 compromised the protective effect of exogenous irisin on lung IR injury. Genetic ablation of UCP2 compromised the protective.
Fig. 7. mRIPO therapy restricts tumor growth and produces antigen-specific antitumor immunity. mRIPO therapy restricts tumor growth and produces antigen-specific.
Fig. 2. IL-2/rapamycin–expanded T cells express homing receptors to traffic to lymphoma sites and are resistant to SN-38 toxicity. IL-2/rapamycin–expanded.
Fig. 4. Efficacy of C12G6 compared with and in combination with oseltamivir in mice. Efficacy of C12G6 compared with and in combination with oseltamivir.
Fig. 3 Agonists of innate immunity are effective only when released locally from the hydrogel. Agonists of innate immunity are effective only when released.
Fig. 1 CSPG4 is expressed in GBM specimens and GBM-NS and associated with more aggressive disease. CSPG4 is expressed in GBM specimens and GBM-NS and associated.
Fig. 6. CXM correlates with age and growth velocity.
Fig. 3 CSF1 is expressed in human melanoma.
Fig. 7 Analysis of the bacterial nidus within tissue abscesses by MALDI IMS demonstrates a paucity of calprotectin signal. Analysis of the bacterial nidus.
Decreased weight and adiposity is transmissible via the gut microbiota
Fig. 2 LAEs are characterized by vascular dysfunction, loss of endothelial perfusion and permeability, and perivascular hypoxia. LAEs are characterized.
Fig. 6 Photoreceptor cell survival in the RCS rat retina after transplantation with hESC-RPE cell sheets. Photoreceptor cell survival in the RCS rat retina.
Fig. 5 ALRN-6924 shows robust antileukemic activity in primary AML cells and in vivo. ALRN-6924 shows robust antileukemic activity in primary AML cells.
Fig. 5 Early and modest immune response at day 3 after exposure in Delayed animals. Early and modest immune response at day 3 after exposure in Delayed.
Correlation of reovirus RNA/protein with proliferating tumor cells
Fig. 6 Combination therapy with LVSOD2 and LVshCTGF preserves flap volume and reduces fibrosis after RT. Combination therapy with LVSOD2 and LVshCTGF preserves.
Fig. 4 Lentiviral transgene expression penetrates tissue and provides durable effects in vivo. Lentiviral transgene expression penetrates tissue and provides.
Fig. 4. The effect of combined inhibition of BCL-2 and BCR-ABL on leukemia LT-HSC frequency. The effect of combined inhibition of BCL-2 and BCR-ABL on.
Fig. 4 High P-eIF2α expression in human prostate tumors with loss of PTEN function is associated with increased risk of metastasis or death after surgery.
Genetic EGFR ablation in K-RAS–mutated lung AC reduces tumor growth
Vaccine MN confer protective innate and adaptive immunity.
HECTD2 knockdown ameliorates Pseudomonas-induced lung injury in vivo
In vivo assessment of synergistic activity of MV-CEA and RT in a U87 s
Fig. 2 Extended local release of agonists of innate immunity prevents tumor recurrence and eliminates distal metastases. Extended local release of agonists.
PD and efficacy of AZD4785 in KRAS mutant lung cancer xenograft models
Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues by Aadil A. Khan, James.
Fig. 1 Irradiation with 50 Gy/3 fractions generates LAE characterized by SOD2 depletion and CTGF overexpression. Irradiation with 50 Gy/3 fractions generates.
The responses of H292 and A549 lung cancer xenografts to hypofractionated radiation were enhanced by the ketogenic diet. The responses of H292 and A549.
Fig. 5 In vivo autologous self-targeting efficacy of DR-KO tumor cells co-engineered with a secretable DRL and a suicide system. In vivo autologous self-targeting.
Fig. 6. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex vivo. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex.
Fig. 3 Superiority of BAFF-R versus CD19-CAR T cells in a Burkitt lymphoma model is not due to greater tumor antigen density. Superiority of BAFF-R versus.
Fig. 1. Schematic description of whole-exome or targeted next-generation sequencing analyses. Schematic description of whole-exome or targeted next-generation.
Presentation transcript:

Fig. 8 SOD2 overexpression in normal tissues does not compromise the cytotoxic efficacy of RT. SOD2 overexpression in normal tissues does not compromise the cytotoxic efficacy of RT. (A) Conditioned medium experiment to assess transmissibility of SOD2 overexpression after exposure of target cells (HeLa) to supernatant (HeLa-SOD2 supernatant) taken from producer cells (HeLa_SOD2) (blot representative of n = 3 biological repeats). (B) Schematic of the in vivo tumor recurrence model showing tumor (red arrow) growing in an SIEA flap (paddle outline dashed white). Animals with tumors greater than 2 cm in diameter were deemed to have exceeded the experimental severity limit and euthanized. (C) Tumor volume growth (mean ± SEM) for Mat B III tumors after RT in flaps infected with LVSOD2, LVeGP, or sham (PBS) (n = 5 animals per group). (D) Individual growth curves for tumors growing in sham (PBS)–infected and unirradiated, sham (PBS)–infected and irradiated (20 Gy/5 fractions), LVSOD-infected and irradiated (20 Gy/5 fractions), or LVeGFP-infected and irradiated (20 Gy/5 fractions) flaps (n = 5 animals per group). (E) Kaplan-Meier plot of survival to severity limit (2- cm tumor diameter) for animals with Mat B III tumors grown in sham (PBS)–, LVSOD2-, or LVeGFP-infected flaps. Median survival is shown at the bottom right. n/a, not applicable. Aadil A. Khan et al., Sci Transl Med 2018;10:eaar2041 Published by AAAS